Cargando…
The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
Alzheimer’s disease (AD), the most common form of dementia in elderly individuals, is marked by progressive neuron loss. Despite more than 100 years of research on AD, there is still no treatment to cure or prevent the disease. High levels of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs)...
Autores principales: | Jasiecki, Jacek, Targońska, Monika, Wasąg, Bartosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922581/ https://www.ncbi.nlm.nih.gov/pubmed/33670778 http://dx.doi.org/10.3390/ijms22042033 |
Ejemplares similares
-
Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?
por: Jasiecki, Jacek, et al.
Publicado: (2019) -
Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021) -
Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer’s disease
por: Jasiecki, Jacek, et al.
Publicado: (2019) -
New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter
por: Jońca, Joanna, et al.
Publicado: (2015) -
Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants
por: Jasiecki, Jacek, et al.
Publicado: (2023)